+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Global Briefing 2018

  • ID: 4452391
  • Report
  • Region: Global
  • 33 pages
  • The Business Research Company
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Medtronic Plc
  • MORE
Cardiovascular drugs market covers the drugs used to treat conditions that affect the heart or blood vessels. These conditions include heart stroke, coronary artery diseases, valvular diseases, peripheral venous diseases, pericarditis, endocarditis, cardiac tumors, arteriosclerosis, and lymphatic diseases. Some of the major cardiovascular drugs include anti-hypertensive drugs such as calcium channel blockers and Angiotensin II receptor antagonists, and hypolipidemic drugs such as fibric acid derivatives and bile acid binding resins.

The market numbers within this briefing are restricted to pharmaceutical (drug) treatments and do not cover biologic treatments for these conditions which are included in a separate briefing.

The Cardiovascular Drugs Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs market.

Reasons to Purchase:
  • Fully updated for 2018.
  • Identify growth segments and opportunities.
  • Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
  • Develop strategies based on likely future developments.
  • Gain a global perspective on the development of the market.
Description

The Cardiovascular Drugs Market Global Briefing 2018 covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the cardiovascular drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the cardiovascular drugs market and suggests approaches.

Scope:

Markets Covered: Cardiovascular Drugs, Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases.
Companies Mentioned: Medtronic Plc, Abbott Laboratories Inc. and Boston Scientific Corporation
Geographic Scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East and Africa.
Time Series: Five years historic and forecast.
Data: Market value in $ billions.
Data Segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Medtronic Plc
  • MORE
Cardiovascular Drugs Market Characteristics
Cardiovascular Drugs Market Historic Growth (2013 - 2017)
Cardiovascular Drugs Market Forecast Growth (2017 - 2021)
Cardiovascular Drugs Market Segmentation
Global Cardiovascular Drugs Market, Split by Segments, 2017, $ Billion
Anti-hypertensive Drugs
Hypolipidemics
Anti Thrombotics
Global Cardiovascular Drugs Market, Historic and Forecast, Split by Segments, 2013 - 2021
Cardiovascular Drugs Market Geography Regional and Country Comparison
Global Cardiovascular Drugs Market, Split by Regions, 2017
Global Cardiovascular Drugs Market, Historic and Forecast Growth Rate, Split by Region, 2013 - 2021
Global Cardiovascular Drugs Market, Split by Country, 2017
Global Cardiovascular Drugs Market, Historic and Forecast Growth Rate, Split by Country, 2013 - 2021
Cardiovascular Drugs Market Competitive Landscape
Merck & Co
Sanofi S.A
Pfizer Inc
Bristol-Myers Squibb Company
Novartis AG
Eli Lilly and Company
Johnson & Johnson
AstraZeneca Plc
Abbott Laboratories Inc
Bayer AG
Merck & Co
Sanofi
Pfizer
Cardiovascular Drugs Market Key Mergers and Acquisitions
Teva Acquired Allergan’s Generic Business
Pfizer Acquired Hospira
AstraZeneca Acquired ZS Pharma
AstraZeneca Acquired Omthera Pharmaceuticals
Bristol-Myers Squibb Acquired Cardioxyl Pharmaceuticals
Cardiovascular Drugs Market Trends and Strategies
Novel Oral Anti-coagulants (NOACs) To Prevent Thrombosis
Approval of New Drugs For Treatment of Chronic Heart Failure
Personalized Medicine For Treatment of Cardiovascular Disorders
Big Data
Appendix
NAICS Definitions of Industry Covered in This Report
Definition of Market Covered in This Report
Abbreviations
Currencies
Research Methodology
Research Inquiries
About the Publisher

List of Figures
Figure 1: Global Cardiovascular Drugs Market, Historic Market Size, 2013 - 2017, $ Billion
Figure 2: Global Cardiovascular Drugs Market, Forecast Market Size, 2017 - 2021, $ Billion
Figure 3: Global Cardiovascular Drugs Market, Split by Segments, 2017, $ Billion
Figure 4: Global Cardiovascular Drugs Market, Historic and Forecast, Split by Segment, 2013 - 2021
Figure 5: Global Cardiovascular Drugs Market, Split by Region, 2017, $ Billion
Figure 6: Global Cardiovascular Drugs Market, Historic and Forecast Growth Rate, Split by Region, 2013 - 2021
Figure 7: Global Cardiovascular Drugs Market, Split by Country, 2017, $ Billion
Figure 8: Global Cardiovascular Drugs Market, Historic and Forecast Growth Rate, Split by Country, 2013 - 2021
Figure 9: Global Cardiovascular Drugs Market, Key Competitor Estimated Market Shares, 2017, Percentage (%)

List of Tables
Table 1: Global Cardiovascular Drugs Market, Historic Market Size, 2013 - 2017, $ Billion
Table 2: Global Cardiovascular Drugs Market, Forecast Market Size, 2017 - 2021, $ Billion
Table 3: Global Cardiovascular Drugs Market, Split by Segments, 2017, $ Billion
Table 4: Global Cardiovascular Drugs Market, Historic and Forecast, Split by Segment, 2013 - 2021
Table 5: Global Cardiovascular Drugs Market, Split by Region, 2017, $ Billion
Table 6: Global Cardiovascular Drugs Market, Historic and Forecast Growth Rate, Split by Region, 2013 - 2021
Table 7: Global Cardiovascular Drugs Market, Split by Country, 2017, $ Billion
Table 8: Global Cardiovascular Drugs Market, Historic and Forecast Growth Rate, Split by Country, 2013 - 2021
Table 9: Global Cardiovascular Drugs Market, Key Competitor Estimated Market Shares, 2017, Percentage (%)
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Medtronic Plc
  • MORE
Cardiovascular drugs market covers the drugs used to treat conditions that affect the heart or blood vessels. These conditions include heart stroke, coronary artery diseases, valvular diseases, peripheral venous diseases, pericarditis, endocarditis, cardiac tumors, arteriosclerosis, and lymphatic diseases. Some of the major cardiovascular drugs include anti-hypertensive drugs such as calcium channel blockers and Angiotensin II receptor antagonists, and hypolipidemic drugs such as fibric acid derivatives and bile acid binding resins.

North America was the largest region in the cardiovascular drugs market in 2017, accounting for around 40% market share. This can be attributed to the high level of healthcare facilities, awareness among people, and GDP of the country. Asia Pacific was the second largest region accounting for around 23% market share. The prevalence of cardiovascular diseases is high in this region. Other factors contributing to the market include availability of a large number of generic drugs, and increasing treatment facilities. Western Europe was the third largest region accounting for around 20% market share.

Companies in the market are focusing on R&D. Areas of development include pacemakers, coronary stents, angioplasty products and implantable cardiac defibrillators. for instance, introduction of bio absorbable vascular stents in percutaneous coronary interventions is promising. in July 2016, the FDA approved the first fully absorbable stent, Absorb GT1 BVS manufactured by Abbott Vascular for coronary artery disease. It offers a new treatment option for patients undergoing angioplasty and opting for absorbable devices instead of metallic stents. in April 2016, FDA approved the world’s first leadless pacemaker, Micra Transcatheter Pacemaker System to treat heart rhythm disorders, which is manufactured by Medtronic Plc. This pacemaker can deliver percutaneously directly into the right ventricle through a minimally invasive approach, and does not require the use of wired leads in providing electrical connection between heart and pulse-generating devices.
Note: Product cover images may vary from those shown
5 of 5
  • Medtronic Plc
  • Abbott Laboratories Inc.
  • Boston Scientific Corporation
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4452391
Adroll
adroll